Steven Hill
Vorstandsvorsitzender bei NEWHYDROGEN, INC.
Vermögen: - $ am 30.04.2024
Profil
Steven Hill is currently the Chief Executive Officer & Director at NewHydrogen, Inc. Prior to his current position, he served as the Managing Member at Hill Investments LLC from 2016 to 2023.
Before that, he worked as a Regional Account Manager at Relypsa, Inc. from 2015 to 2021.
Mr. Hill holds an MBA from Instituto de Empresa SL and an undergraduate degree from Utah Valley University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NEWHYDROGEN INC
0,00% | 15.03.2024 | 3 ( 0,00% ) | 0 $ | 30.04.2024 |
Aktive Positionen von Steven Hill
| Unternehmen | Position | Beginn |
|---|---|---|
| NEWHYDROGEN, INC. | Vorstandsvorsitzender | 15.06.2023 |
Ehemalige bekannte Positionen von Steven Hill
| Unternehmen | Position | Ende |
|---|---|---|
| Hill Investments LLC | Corporate Officer/Principal | 01.02.2023 |
| RELYPSA INC | Comptroller/Controller/Auditor | 01.10.2021 |
Ausbildung von Steven Hill
| Instituto de Empresa SL | Masters Business Admin |
| Utah Valley University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
| NewHydrogen, Inc. | |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
| Hill Investments LLC |
